AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Physicians’ Education Resource® to Present Evolutions in the Treatment and Management of Advanced Cervical Cancer: Leveraging the Immunosuppressive Microenvironment, Addressing Ongoing Clinical Needs

February 28, 2019

CRANBURY, N.J.--(BUSINESS WIRE)--Feb 28, 2019--Physicians’ Education Resource® (PER®), a worldwide leading resource for oncology and hematology continuing medical education (CME), will conduct a live CME accredited activity entitled Evolutions in the Treatment and Management of Advanced Cervical Cancer: Leveraging the Immunosuppressive Microenvironment, Addressing Ongoing Clinical Needs as a satellite symposium adjunct to the Society of Gynecologic Oncology’s (SGO) 50 th Annual Meeting on Women’s Cancer. The program will take place on Saturday, March 16, from 11:00 a.m. to 12:30 p.m. at the Hawaii Convention Center in Honolulu.

The educational program will be chaired by Bradley J. Monk, M.D., FACS, FACOG, a professor and director of the division of gynecologic oncology at Creighton University School of Medicine at St. Joseph’s Hospital and Medical Center in Phoenix, Arizona.

“We look forward to present this program on the evolutions in the treatment and management of cervical cancer using novel immunotherapies at this year’s SGO annual meeting on women’s cancer,” said Phil Talamo, president of PER®. “These breakthroughs in care are changing the way we have treated cervical cancer and clinicians need education on the best ways to leverage these new strategies.”

During this live activity, Monk, along with other faculty experts in the field of cervical cancer, will explore recent clinical developments through didactic presentations, case-based discussions, and panel interactions with the audience. The faculty will also cover a wide range of topics, including the current landscape of treatment options for patients with cervical cancer, recent advancements in the understanding of the tumor microenvironment and how this influences immune response, the evolving role of immunotherapeutic for cervical cancer and emerging biomarkers that may govern treatment selection for patients.

This live activity is accredited by the Accreditation Council for Continuing Medical Education for 1.5 AMA PRA Category 1 Credits ™ for physicians. For more information and to register, click here.

About Physicians’ Education Resource ®

Since 1995, PER ® has been dedicated to advancing cancer care through professional education and now furthers patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER ® initiated CME programming in the cardiovascular and endocrinology areas and continues to grow its therapeutic reach outside oncology. While continuing to expand into topics outside of oncology, PER ® remains the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER ® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER ® is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses. Learn more at  http://www.gotoper.com and  http://www.mjhassoc.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190228005703/en/

CONTACT: PER® MediaContacts

Alexandra Ventura, 609-716-7777, ext. 121

aventura@mjhassoc.com

John Patricolo, 609-325-4630

jpatricolo@mjhassoc.com

KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY

INDUSTRY KEYWORD: HEALTH HOSPITALS ONCOLOGY RESEARCH OTHER SCIENCE SCIENCE

SOURCE: Physicians’ Education Resource

Copyright Business Wire 2019.

PUB: 02/28/2019 11:23 AM/DISC: 02/28/2019 11:23 AM

http://www.businesswire.com/news/home/20190228005703/en